TickerKhojComparison · NSE · data 2026-11-03
Dr. Lal PathLabs Limited vs Metropolis Healthcare Ltd.
In plain words
Size: Dr. Lal PathLabs Limited is about 2.7 times the market value of Metropolis Healthcare Ltd..
Return on equity: Dr. Lal PathLabs Limited 21.6% vs Metropolis Healthcare Ltd. 13.4%.
Profit growth over 3 years: Dr. Lal PathLabs Limited 28.3% a year vs Metropolis Healthcare Ltd. 10% a year.
Debt to equity: Metropolis Healthcare Ltd. 0.15 vs Dr. Lal PathLabs Limited 0.08.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| LALPATHLAB | METROPOLIS | |
|---|---|---|
| Price | ₹1,925.7 | ₹568.7 |
| Market cap | ₹31,681 cr | ₹11,619 cr |
| P/E | 59.4 | 58.6 |
| P/B | — | — |
| ROE | 21.6% | 13.4% |
| ROCE | 25.3% | 16.3% |
| Debt / equity | 0.08 | 0.15 |
| Operating margin | 23.0% | 16.8% |
| Dividend yield | 0.85% | 0.36% |
| Sales growth, 3 years (yearly) | 11.1% | 12.8% |
| Profit growth, 3 years (yearly) | 28.3% | 10.0% |
| 1-year return | 22.1% | 14.9% |
| Revenue, last 12 months | ₹2,891 cr | ₹1,710 cr |
| Net profit, last 12 months | ₹542 cr | ₹202 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹170 cr | ₹57 cr |
| Quarter profit vs a year earlier | +28.0% | +25.8% |
| Promoter holding | 52.93% | 47.82% |
| Health check | Strong (8/10) | Strong (6.9/10) |
Common questions
Which has a higher P/E, Dr. Lal PathLabs Limited or Metropolis Healthcare Ltd.?
Dr. Lal PathLabs Limited trades at the higher P/E (59.4 against 58.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Dr. Lal PathLabs Limited (21.6% against 13.4%).
Which carries more debt?
Metropolis Healthcare Ltd. has the higher debt-to-equity ratio (0.15 against 0.08).